Frederikus Albertus Klok
Frederikus Albertus Klok publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Pulmonary Hypertension Research and Treatments.
- World rank
- #41,783 of 7,710,434 ranked researchers
- Rank in Netherlands
- #855 of 107,149
- Works
- 680
- Citations
- 34k
- Citations per work
- 49.3
What does Frederikus Albertus Klok research?
Frederikus Albertus Klok's work is mostly in Medicine (73%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences49773.1%
- Medicine49773.1%
- Everything else18326.9%
- 1Internal Medicine30% of their works
- 2Cardiology and Cardiovascular Medicine19% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Surgery8% of their works
- 5Epidemiology5% of their works
- 6Hematology4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Pulmonary Hypertension Research and Treatments
- Acute Ischemic Stroke Management
- Blood Coagulation and Thrombosis Mechanisms
- Diagnosis and Treatment of Venous Diseases
- COVID-19 Clinical Research Studies
- Central Venous Catheters and Hemodialysis
Which keywords describe Frederikus Albertus Klok's research?
The keywords of their largest research topics: Risk Factors, Antithrombotic Therapy, Clinical Practice Guidelines, Pulmonary Embolism, Venous Thromboembolism, Anticoagulant Therapy, Atrial Fibrillation and Epidemiology.
- Central Venous Catheterization
- SARS-CoV-2
- Varicose Veins
- Thrombin
- Thrombolysis
- Right Heart Assessment
- Epidemiology
- Anticoagulant Therapy
- Pulmonary Embolism
- Antithrombotic Therapy
- Risk Factors
- Clinical Practice Guidelines
- Venous Thromboembolism
- Atrial Fibrillation
- Pulmonary Hypertension
- Ischemic Stroke
- Protease-Activated Receptors
- Chronic Venous Insufficiency
- Clinical Characteristics
- Catheter-Related Infections
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Risk Factors6162 topics
- Antithrombotic Therapy6082 topics
- Clinical Practice Guidelines6022 topics
- Pulmonary Embolism5461 topic
- Venous Thromboembolism5461 topic
- Anticoagulant Therapy2221 topic
- Atrial Fibrillation2221 topic
- Epidemiology1082 topics
- Pulmonary Hypertension791 topic
- Right Heart Assessment791 topic
- Ischemic Stroke701 topic
- Thrombolysis701 topic
- Protease-Activated Receptors621 topic
- Thrombin621 topic
- Chronic Venous Insufficiency561 topic
- Varicose Veins561 topic
- Clinical Characteristics521 topic
- SARS-CoV-2521 topic
- Catheter-Related Infections451 topic
- Central Venous Catheterization451 topic
Where does Frederikus Albertus Klok work?
Frederikus Albertus Klok's main affiliation in the publication record is Leiden University Medical Center, Netherlands.
How many publications and citations does Frederikus Albertus Klok have?
OpenAlex counts 680 works and 33,532 citations for Frederikus Albertus Klok, an h-index of 78, ranking #41,783 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frederikus Albertus Klok. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.